T2 2339-1034SRecalls & reported problems

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 07613327292442), received between Oct 26, 2022 and Jan 14, 2026 — classified as 2 injuries.

The most frequently reported specific device problem is “Fracture” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

• InjuryJan 14, 2026Fracture

  IT WAS REPORTED THAT THE IMPLANT FAILED ABOUT 3 MONTHS POST-OP.

  Patient problems: Insufficient Information

  MAUDE report 24073089 ↗
• InjuryOct 26, 2022Break; Fracture; Break; Fracture

  IT WAS REPORTED THAT A T2 ALPHA RETROGRADE NAIL WAS DISCOVERED TO BE BROKEN AT THE MOST PROXIMAL SCREW HOLE IN THE DISTAL CLUSTER OF THE NAIL. THE SCREW WAS FOUND TO BE BROKEN DURING EXPLANTATION OF THE NAIL. PATIENT WAS GIVEN WEIGHT BEARING AS TOLERATED INSTRUCTIONS POSTOPERATIVELY. PATIENT WAS REVISED TO A T2 SCN WITH ENDCAP. PRIMARY IMPLANT DATE WAS ON (B)(6) 2022. PATIENT TOOK NOTICE ON (B)(6), AFTER FALLING DOWN AND FEELING PAIN. NAIL HAS BEEN RETURNED.

  Patient problems: Failure of Implant; Implant Pain

  MAUDE report 15672328 ↗